Overview


According to FutureWise analysis the market for Neurodiagnostics in 2023 is US$ 8.01 billion, and is expected to reach US$ 13.99 billion by 2031 at a CAGR of 7.22%.

Neurodiagnostics is the field of medicine that focuses on the diagnosis and treatment of disorders related to the nervous system. This can include disorders of the brain, spinal cord, nerves, and muscles. The nervous system is an intricate network of cells, tissues, and organs that operate together to control many functions of the body, such as movement, sensation, and thought. Neurodiagnostic testing can help healthcare providers diagnose and treat various neurological disorders, such as epilepsy, multiple sclerosis, Alzheimer's disease, Parkinson's disease, and many others.

Neurodiagnostics tests may involve the use of advanced imaging techniques, such as MRI scans, CT scans, and PET scans, as well as electroencephalography (EEG), nerve conduction studies (NCS), and electromyography (EMG). EEG is a non-invasive test that measures electrical activity in the brain. It can help detect abnormal brain activity, which may be a sign of conditions such as epilepsy or sleep disorders. NCS and EMG are tests that measure the electrical activity of nerves and muscles. These tests can aid in the diagnosis of diseases such as carpal tunnel syndrome, peripheral neuropathy, and muscular dystrophy. Neurodiagnostics is a rapidly advancing sector, with new technology and approaches emerging on a regular basis. Neurodiagnostic testing will become increasingly significant in the diagnosis and treatment of neurological illnesses as our understanding of the nervous system advances.

FutureWise Market Research has published a report that provides an insightful analysis of Neurodiagnostics Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Neurodiagnostics Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • GE Healthcare
  • Siemens Healthineers
  • Philips Healthcare
  • Canon, Inc.
  • Hitachi, Ltd.
  • Lifelines Neuro Company, LLC
  • Natus Medical Incorporated
  • Hoffman-La Roche AG
  • FUJIFILM Holdings Corporation
  • Mitsar Co., Ltd.
  • Advanced Brain Monitoring
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories
  • QIAGEN N.V.
  • Nihon Kohden Corporation

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Neurodiagnostics Market:

  • In May 2022, Revolutionary 7 Tesla and 9.4 Tesla conduction-cooled Maxwell magnets were introduced by Bruker for their preclinical MRI range. These magnet series offer high-field sensitivity and resolution for innovative preclinical MRI and PET/MR studies while removing the requirement for liquid helium or nitrogen refills.

The neurodiagnostics market is a rapidly growing segment of the healthcare industry, driven by several key factors. One of the primary drivers of the neurodiagnostics market is the rising prevalence of neurological disorders. The World Health Organisation (WHO) estimates that up to 1 billion individuals worldwide suffer from neurological illnesses, and that number is anticipated to grow as the world's population ages. The growing prevalence of neurological disorders is driving demand for neurodiagnostic procedures to aid in diagnosis and treatment. Another factor driving growth in the neurodiagnostic market is technological advancements in diagnostic imaging and monitoring equipment. The development of high-resolution imaging technologies such as MRI scans and CT scans has increased the accuracy and efficiency of neurodiagnostic procedures. In addition, the development of portable and wireless monitoring devices has increased the convenience and accessibility of these procedures, making them more viable options for patients who require ongoing neurological monitoring. Furthermore, the increasing adoption of telemedicine has also contributed to the growth of the neurodiagnostics market. Telemedicine enables patients to receive neurodiagnostic services remotely, which can help to improve patient access to care and reduce healthcare costs.

Despite the growth prospects, there are also several challenges faced by the neurodiagnostics market. One of the significant challenges is the high cost of neurodiagnostic equipment and procedures, which can be a barrier to access for some patients.

By Product

  •     Diagnostic and Imaging Systems
    •      Electroencephalogram (EEG) Systems
    •      Electromyography (EMG) Products
    •      Magnetic Resonance Imaging (MRI) Systems
    •      Ultrasound Imaging Systems
    •      Computed Tomography (CT) Scanner
    •      Magnetoencephalogram (MEG) System
    •      Position emission tomography (PET) System
    •      Angiography System
    •      Other Systems
  • Clinical Testing Instruments
    •      PCR
    •      Next-Generation Sequencing (NGS)
    •      Sanger Sequencing
    •      Other Clinical Diagnostic Products
  • Reagents & Consumables
    •      Media and Serra
    •      Solvents
    •      Enzymes, Protein & Peptides
    •      Probes
    •      Buffers
    •      Antibodies
    •      Other Reagents

 By Disease Pathology

  • Neuro Degenerative Diseases
  • Epilepsy
  • Stroke
  • Headache Disorders
  • Sleep Disorders
  • Other Diseases

By End User

  • Hospitals and Surgery Centers
  • Neurology Centers
  • Ambulatory Care Centers
  • Diagnostic Laboratories & Imaging Centers
  • Research Laboratories & Academic Institutes

By Region

  • North America
  • Latin America
  • Europe
  • Asia-Pacific
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. Additionally, North America registered the highest share of 8.4% in the global market in 2022. Due to the increasing incidence of neurological disorders, a growing elderly population, a strong healthcare infrastructure, significant healthcare expenditures, and the presence of major market players who are constantly developing and releasing advanced diagnostics devices in the region, North America is anticipated to account for the major market share in the global neurodiagnostics market. The primary reason fueling the market's expansion in the region is the increased frequency of neurological illnesses. For instance, the Chief Science Officer of the Alzheimer Society of Canada indicated in an interview in June 2021 that "Over the coming ten years, it is anticipated that over 1 million individuals in Canada will be living with dementia." This shows that the rising incidence of Alzheimer's in the North American region is anticipated to raise demand for diagnostic and imaging systems, which might further fuel market expansion during the forecast period

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting the market growth

  • To provide with an exhaustive analysis on the Neurodiagnostics Market By Product, By Disease Pathology, By End User and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with the purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Neurodiagnostics Market Variables, Trends and Scope
    •      1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Neurodiagnostics Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Neurodiagnostics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Neurodiagnostics Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Diagnostic Imaging Systems
         1.1 . MRI Systems
         1.2 . EEG Systems
         1.3 . CT Scanners
         1.4 . PET Scanners
         1.5 . EMG Devices
         1.6 . Ultrasound Imaging Systems
         1.7 . MEG Devices
         1.8 . Angiography Systems
         1.9 . Other Diagnostic Imaging Systems
        2. Clinical Diagnostic Instruments
         2.1 . PCR Instruments
         2.2 . NGS Instruments
         2.3 . Sanger Sequencers
         2.4 . Other Clinical Diagnostic Instruments
        3. Reagents and Consumables
         3.1 . Media and Sera
         3.2 . Antibodies
         3.3 . Buffers
         3.4 . Solvents
         3.5 . Enzymes, Proteins, and Peptides
         3.6 . Probes
         3.7 . Other Reagents and Consumables

  • 8.   Neurodiagnostics Market, By Disease Pathology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Neurodegenerative Diseases
        2. Stroke
        3. Epilepsy
        4. Headache Disorders
        5 . Sleep Disorders
        6 . Other Diseases

  • 9.   Neurodiagnostics Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals and Surgical Centers
        2. Diagnostic Laboratories and Imaging Centers
        3. Neurology Centers
        4. Ambulatory Care Centers
        5. Research Laboratories and Academic Institutes

  • 10.   North America Neurodiagnostics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Neurodiagnostics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Neurodiagnostics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Neurodiagnostics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. GE Healthcare
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Siemens Healthineers
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Philips Healthcare
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Canon, Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Hitachi, Ltd.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Lifelines Neuro Company, LLC
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Natus Medical Incorporated
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Hoffman-La Roche AG
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. FUJIFILM Holdings Corporation
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Mitsar Co., Ltd.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11.Advanced Brain Monitoring
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12.Thermo Fisher Scientific, Inc.
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13.Bio-Rad Laboratories
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14.QIAGEN N.V.
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15.Nihon Kohden Corporation
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients